![Helen Torley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Helen Torley
Directeur Général chez
HALOZYME THERAPEUTICS, INC.
Fortune : 51 M $ au 31/05/2026
Profil
Helen I. Torley occupe le poste de présidente, directrice générale et directrice chez Halozyme Therapeutics, Inc. Elle est également membre du conseil d'administration de Quest Diagnostics, Inc., directrice et membre du conseil d'administration de la section santé de la Biotechnology Innovation Organization et membre du Royal College of Physicians. Dans le passé, elle a été vice-présidente et directrice générale de la santé osseuse aux États-Unis chez Amgen, Inc. et directrice commerciale et vice-présidente exécutive d'Onyx Pharmaceuticals, Inc. (une filiale d'Amgen, Inc.), vice-présidente des affaires médicales de Novartis, Inc. et vice-présidente des affaires médicales de Sandoz SA, ainsi que vice-présidente des ventes de produits cardiovasculaires et métaboliques du Bristol-Myers Squibb World Wide Medicines Group. Elle a obtenu un diplôme de premier cycle à l'université de Glasgow.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 03/06/2026 | 767 780 ( 0,65 % ) | 51 M $ | 31/05/2026 |
Postes actifs de Helen Torley
| Sociétés | Poste | Début |
|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Directeur Général | 06/01/2014 |
| ANTARES PHARMA, INC. | Directeur/Membre du Conseil | 24/05/2022 |
The Royal College of Physicians
 The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Directeur/Membre du Conseil | - |
Anciens postes connus de Helen Torley
| Sociétés | Poste | Fin |
|---|---|---|
| QUEST DIAGNOSTICS INCORPORATED | Directeur/Membre du Conseil | 18/05/2022 |
| RELYPSA INC | Directeur/Membre du Conseil | 01/09/2016 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Directeur des opérations | 15/12/2011 |
| AMGEN INC. | Corporate Officer/Principal | 01/01/2011 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/2002 |
Formation de Helen Torley
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
76
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
Antares Pharma, Inc.
 Antares Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops parenteral pharmaceutical products | Health Technology |
Quest Diagnostics, Inc.
 Quest Diagnostics, Inc. Services to the Health IndustryHealth Services Provides diagnostic testing and information services | Health Services |
Novartis, Inc.
 Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco, CA. | Health Technology |
Halozyme Therapeutics, Inc.
 Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
University of Glasgow
 University of Glasgow Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Relypsa, Inc.
 Relypsa, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops non-absorbed polymeric drugs for applications in cardiovascular and renal diseases | Health Technology |
Sandoz SA |
